- Home
- DIT vs CTOR Comparison
DIT vs CTOR Comparison
Compare DIT & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- CTOR
- Stock Information
- Founded
- DIT 1981
- CTOR 2021
- Country
- DIT United States
- CTOR United States
- Employees
- DIT N/A
- CTOR N/A
- Industry
- DIT Food Distributors
- CTOR
- Sector
- DIT Consumer Discretionary
- CTOR
- Exchange
- DIT Nasdaq
- CTOR NYSE
- Market Cap
- DIT 78.7M
- CTOR 63.7M
- IPO Year
- DIT 1995
- CTOR N/A
- Fundamental
- Price
- DIT $115.50
- CTOR $5.30
- Analyst Decision
- DIT
- CTOR Buy
- Analyst Count
- DIT 0
- CTOR 2
- Target Price
- DIT N/A
- CTOR $6.00
- AVG Volume (30 Days)
- DIT 590.0
- CTOR 3.3M
- Earning Date
- DIT 07-17-2025
- CTOR 08-11-2025
- Dividend Yield
- DIT 0.87%
- CTOR N/A
- EPS Growth
- DIT N/A
- CTOR N/A
- EPS
- DIT 2.44
- CTOR N/A
- Revenue
- DIT $2,221,421,072.00
- CTOR N/A
- Revenue This Year
- DIT N/A
- CTOR N/A
- Revenue Next Year
- DIT N/A
- CTOR N/A
- P/E Ratio
- DIT $47.39
- CTOR N/A
- Revenue Growth
- DIT 7.47
- CTOR N/A
- 52 Week Low
- DIT $94.92
- CTOR $0.55
- 52 Week High
- DIT $166.00
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- DIT 57.52
- CTOR N/A
- Support Level
- DIT $100.08
- CTOR N/A
- Resistance Level
- DIT $115.00
- CTOR N/A
- Average True Range (ATR)
- DIT 5.01
- CTOR 0.00
- MACD
- DIT 1.78
- CTOR 0.00
- Stochastic Oscillator
- DIT 94.25
- CTOR 0.00
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.